Study: CBD Reduces Cocaine Intake

According to a new study published by the journal Neuropharmacology, cannabidiol (CBD) reduces cocaine intake and has “pro-neurogenic effects” in cocaine consuming animals.

(Photo: Dmitry Tishchenko – Getty Images).

The study, titled Repeated Cannabidiol treatment reduces cocaine intake and modulates neural proliferation and CB1R expression in the mouse hippocampus, was epublished by the National Institute of Health.

“Cannabinoid derivatives have shown promising results for treating neuropsychiatric disorders, including drug addiction”, begins the study’s abstract. “To determine whether CBD can attenuate cocaine reinforcement, we assessed behavioural responses induced by cocaine in mice, using the behavioural sensitization, conditioned place preference and intravenous self-administration paradigms.”

Continue reading

PTSD is the Most Common Condition Treated by Medical Cannabis in Illinois

In Illinois, the number of patients who use medical cannabis for post traumatic stress disorder (PTSD) surpasses that of any other condition, according to a new state report.

The report states that PTSD has become the most common medical ailment among patients who are participating in the state’s legal medical cannabis program. The report also found that the program has grown 83% this year to over 46,000 patients.

The number of patients with PTSD who are legal medical cannabis patients doubled in fiscal year 2018, to more than 4,000. This surpassed fibromyalgia (3,400 patients), and cancer (2,500 patients), which were #1 and #2 last year. Rounding out the top five are spinal cord disease and injuries and traumatic brain injuries.

Continue reading

Oregon Garnered Over $10 Million in Marijuana Taxes in August, Setting New Monthly Record

According to the Oregon Department of Revenue, the state made over $10 million in taxes from legal marijuana sales in August.

In total, Oregon garnered $10,114,594 million in marijuana taxes in August, narrowly beating  out the previous monthly record set in July (the record before that was the $9.2 million made in January). August’s taxes were made from the sale of around $50 million worth of marijuana and marijuana products.

Of the $10.1 million in marijuana taxes made in August, $8,791,774 came from the state’s tax on marijuana; the remaining $1,322,820 came from local taxes.

Continue reading

Study: Fewer Sexually Transmitted Infections Found in Men Who Use Cannabis

In a new study published being published in the journal Sexually Transmitted Diseases, and epublished online by the National Institute of Health, men who consume cannabis and no other drugs were found to have less sexually transmitted infections.

“Among men who have sex with men (MSM) the relationship between sexually transmitted infections (STIs) and cannabis use is not well established”, states the study’s abstract. With this in mind, reseachers “assessed cannabis use, sexual behavior, and STIs including HIV in a diverse cohort of young MSM.”

For the study researchers “conducted visits every 6 months with 512 MSM between 2014 and 2017 collecting demographics, sexual behaviors, and reports of frequency of substance use. Each visit conducted testing for gonorrhea, chlamydia and syphilis via blood, urine, and pharyngeal and rectal swabs by PCR, HIV was assessed using rapid tests for HIV negatives and viral load for HIV positives.” Researchers “analyzed the relationship between cannabis use, sexual behaviors and STIs/HIV across 1,535 visits.”

Continue reading

iHeartMedia Invests $10 Million in High Times

iHeartMedia announced today that they would make a strategic investment deal with High Times Holding Corp. The $5,000,000 advertising deal comes alongside a $10,000,000 investment.

Per the terms of the agreement, High Times will gain access to the radio brand’s “inventory, outdoor advertising, mass media expertise, and other associated services”. iHeart will commit to High Times a minimum of $5,000,000 worth of advertising media inventory on the iHeart broadcast radio stations throughout the United States, as well as on its Clear Channel out-of-home advertising billboards. High Times intends to utilize the ad media inventory purchases to publicize its pending maximum $50 million Regulation A+ initial public offering.

“The synergies are obvious,” said Adam Levin, chairman and CEO of High Times. “While TV and movies influence culture, music and events define it. This strategic alignment gives both organizations a vested interest in each other and sets the stage for some really interesting collaborations in the future.”

Continue reading

Jamaica Makes First-Ever Shipment of Medical Marijuana to Canada

Jamaica has officially made its first-ever shipment of medical marijuana to Canada.

“Jamaica is uniquely positioned to be a global player and we are committed to providing the leadership and resources required for opening the international markets including Canada and Europe for our licensed and regulated Jamaican companies”, says Minister of Industry, Commerce, Agriculture and Fisheries Audley Shaw, in an announcement regarding the shipment.

The shipment was authorized through an import permit issued by the Government of Canada through Health Canada for Jamaica and an export permit issued by the Ministry of Health in Jamaica. The import permit from Health Canada was obtained on behalf of Jamaican-based licensed producer Timeless Herbal Care which was then granted an export permit by the Ministry of Health in Jamaica.

Continue reading

Pennsylvania Committee Unanimously Passes Resolution Urging Feds to Legalize Hemp

A resolution urging the federal government to end the nation’s longstanding prohibition on industrial hemp has been passed by a key legislative committee in Pennsylvania.

Senate Resolution 421 was passed unanimously (11 to 0) yesterday by the Senate Agriculture and Rural Affairs Committee.

According to its official summary, SR 421 is “A Resolution urging the Congress of the United States to pass the language from the Hemp Farming Act of 2018, as contained in the 2018 Farm Bill, removing industrial hemp from the Schedule I Controlled Substance List and legalizing commercial industrial hemp production in the United States”.

Continue reading

Study: CBD-Rich Cannabis Extracts Present “a Better Therapeutic Profile” Than Pure CBD

CBD-rich extracts which contain at least a small amounts of other cannabinoids “present a better therapeutic profile” than CBD alone, according to a new study published by the journal Frontiers in Neurology.

Cannabis oil (photo: David Downs).

The study, titled Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy, states that the improved benefits of high-CBD cannabis extracts over pure CBD “is likely due to synergistic effects of CBD with other phytocompounds (aka Entourage effect)”.

According to the study’s abstract. “This meta-analysis paper describes the analysis of observational clinical studies on the treatment of refractory epilepsy with cannabidiol (CBD)-based products. Beyond attempting to establish the safety and efficacy of such products, we also investigated if there is enough evidence to assume any difference in efficacy between CBD-rich extracts compared to purified CBD products.”

Continue reading

CBD May Help Treat Methamphetamine Dependency, States New Study

Cannabidiol (CBD) can “reduce the motivation to seek and consume methamphetamine”, suggesting it may be effective as a treatment for those addicted to the drug, finds a new study published by the Journal of Psychopharmacology.

“Methamphetamine is an addictive stimulant that can cause many adverse physical, psychological and psychosocial effects”, begins the study’s abstract. “Preliminary evidence shows cannabidiol, a non-intoxicating constituent of the cannabis plant, may have efficacy in treating opioid and nicotine dependence. However, no study has yet examined whether cannabidiol treatment might impact on methamphetamine addiction.”

The current study “investigated whether cannabidiol administration reduces the motivation to self-administer methamphetamine and relapse to methamphetamine-seeking behavior following abstinence.”

Continue reading

Study: Cannabis Oil Reduces Seizures, Improves Quality of Life, in Those with Dravet Syndrome

According to a new study, cannabis oil (containing both CBD and THC) is effective in reducing seizure counts and improving quality of life measures in those with Dravet Syndrome.

An epilepsy word cloud.

The study, titled A prospective open-label trial of a CBD/THC cannabis oil in dravet syndrome, was published by the journal Annals of Clinical and Translational Neurology.  According to the Dravet Foundation, dravet syndrome, also known as Severe Myoclonic Epilepsy of Infancy (SMEI), “is a rare and catastrophic form of intractable epilepsy that begins in infancy”, with “an estimated incidence rate of 1:16,000 to 1:21,000”.

The study’s abstract starts by stating that “Both Δ9 Tetrahydrocannabidiol (THC) and cannabidiol (CBD) components of cannabis, have been shown to have anticonvulsant effects. Cannabis oils are used to treat seizures in drug-resistant epilepsy (DRE).” It then goes on to note that “Recent trials provide data on dosing, side effects, and efficacy of CBD, yet there is a paucity of information on THC in epilepsy.”

Continue reading